Kalypsys
Founder
Kevin Lustig
Founder and CEO, Assay Depot. Founder and Research Director, Kalypsys. Research Director at Tularik (sold to Amgen for $2.5B). Post-doc at Harvard. PhD at UCSF
Founder and CEO, Assay Depot. Founder and Research Director, Kalypsys. Research Director at Tularik (sold to Amgen for $2.5B). Post-doc at Harvard. PhD at UCSF
There was a problem loading your content.
Experience
Tularik
Employee
Kalypsys
Employee
Founder
Employee
Education